bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Fate Therapeutics Inc. logo

    Fate Therapeutics Inc.

    FATE | NASDAQ
    Chart Builder DCF Calculator
    $2.58
    +$0.05 (+1.98%)
    Sep 22, 2026, 1:58 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $294.89M
    Enterprise Value
    $216.8M
    Beta
    2.55
    Average Volume
    3.42M
    Shares Outstanding (Diluted)
    120.4M
    Shares Change YoY
    1.58%
    Institutional Ownership
    61.74%
    Exchange
    NASDAQ
    ISIN
    US31189P1021

    Price Performance

    Price Change 1M
    8.6%
    Price Change 3M
    17.1%
    Price Change 6M
    107.4%
    Price Change YTD
    156.5%
    Price Change 1Y
    150.5%
    Price Change 3Y
    19.9%
    Price Change 5Y
    -96.1%
    1M CAGR (ann.)
    -9.6%
    1Y CAGR (ann.)
    153.0%
    5Y CAGR (ann.)
    -47.9%
    All-Time CAGR
    -7.1%

    Valuation

    PE Ratio
    -2.41
    Forward PE
    N/A
    PEG Ratio
    -0.07
    Forward PEG
    1.52
    PS Ratio
    45.43
    Forward PS
    63.70
    PB Ratio
    1.92
    P/FCF Ratio
    -2.79
    P/Adj. FCF Ratio
    -2.39
    P/OCF Ratio
    -2.98
    EV/Sales
    33.40
    EV/EBIT
    -1.72
    EV/EBITDA
    -1.85
    EV/FCF
    -2.05
    Earnings Yield
    -41.5%
    FCF Yield
    -35.8%
    Adj. FCF Yield
    -41.9%

    Financial Health

    Net Cash
    $153.77M
    Total Debt
    $75.68M
    Cash & Short-Term Investments
    $153.77M
    Total Assets
    $260.1M
    Current Ratio
    4.85
    Quick Ratio
    4.85
    Debt / Equity Ratio
    0.49
    Debt / EBITDA
    -0.65
    Debt / FCF
    -0.72
    OCF / Debt
    -1.35
    Interest Coverage
    0.00
    Altman Z-Score
    -7.93
    Piotroski F-Score
    3

    Margins & Profitability

    Gross Profit Margin
    -343.0%
    Operating Profit Margin
    -2058.1%
    EBITDA Margin
    -1805.3%
    Net Profit Margin
    -1941.1%
    FCF Margin
    -1627.8%
    Adj. FCF Margin
    -1902.5%
    SBC / Revenue
    274.8%
    SBC Impact (per share)
    -16.9%

    Returns

    Return on Assets
    -48.4%
    Return on Equity
    -65.1%
    Return on Invested Capital
    -57.5%
    Return on Capital Employed
    -58.7%
    Return on Tangible Assets
    -48.4%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -62.1%
    Revenue CAGR 5Y
    -33.0%
    Revenue CAGR 10Y
    3.8%
    EPS CAGR 3Y
    23.5%
    EPS CAGR 5Y
    20.1%
    EPS CAGR 10Y
    -2.5%
    FCF CAGR 3Y
    14.7%
    FCF CAGR 5Y
    25.2%
    FCF CAGR 10Y
    -11.8%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    31
    EPS Growth Next 3Y
    -0.3%
    Revenue Growth Next 3Y
    59.6%
    Earnings Date
    Nov 11, 2026
    EPS Estimate (next Q)
    -$0.27
    EPS Growth Est (next Q)
    0.0%
    Revenue Est (next Q)
    $1.17M
    Revenue Growth Est (next Q)
    -32.7%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $5.63
    Price Target Upside
    122.5%

    Cash Flow

    Operating Cash Flow
    $-101.94M
    Free Cash Flow
    $-105.66M
    Adj. Free Cash Flow
    $-123.49M
    FCF Per Share
    -$0.88
    OCF Per Share
    -$0.85
    OCF/S Ratio
    -1570.5%

    Income Statement

    Revenue
    $6.49M
    Gross Profit
    $-22.27M
    Operating Income
    $-133.59M
    EBITDA
    $-117.18M
    Net Income
    $-126M
    EPS (Diluted)
    -$1.05
    Revenue / Employee
    $40.32K
    Profit / Employee
    $-782.58K
    Employees
    161

    © 2026 bestshares.com. All rights reserved.